1.Abou-Nassar K，Brown JR.Novel agents for the treatment of chronic lymphocytic leukaemia.Clin Adv Haematol Oncol，2010，8（12）:886-895.

2.Ahn MY，Kwon SM，Kim YC，et al.Pheophorbide a-mediated photodynamic therapy induces apoptotic cell death in murine oral squamous cell carcinoma in vitro and in vivo.Oncol Rep，2012，27（6）:1772-1778.

3.Ashhab Y，Alian A，Polliack A，et al.Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern.FEBS Lett，2001，495（1-2）:56-60.

4.Carnero A.MAP17and the double-edged sword of ROS.Biochim Biophys Acta，2012，1826 （1）:44-52.

5.Lowe SW，Lin AW.Apoptosis in cancer.Carcinogenesis，2000，21（3）:485-495.

6.Fink SL，Cookson BT.Apoptosis，pyroptosis，and necrosis:mechanistic description of dead and dying eukaryotic cells.Infect Immun，2005，73（4）:1907-1916.

7.Fong PC，Xue WC，Ngan HY，et al.Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study.J Clin Pathol，2006，59（2）:179-183.

8.Fulda S，Meyer E，Debatin KM.Inhibition of TRAIL-induced apoptosis by Bcl-2overexpression.Oncogene，2000，21（15）:2283-2294.

9.Goolsby C，Paniagua M，Tallman M，et al.Bcl-2regulatory pathway is functional in chronic lymphocytic leukaemia.Cytometry B Clin Cytom，2005，63（1）:36-46.

10.Hanahan D，Weinberg RA.The hallmarks of cancer.Cell，2000，100（1）:57-70.

11.Harada T，Harada K，Ueyama Y.The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.Int J Oncol，2012，41（2）:565-572.

12.Kang MH，Reynolds CP.Bcl-2inhibitors:Targeting mitochondrial apoptotic pathways in cancer therapy.Clin Cancer Res，2009，15（4）:1126-1132.

13.Kondo Y，Nagai K，Nakahata S，et al.Overexpression of the DNA sensor proteins，absent in melanoma 2and interferon-inducible 16，contributes to tumorigenesis of oral squamous cell carcinoma with p53inactivation.Cancer Sci，2012，103（4）:782-790.

14.LaCasse EC，Mahoney DJ，Cheung HH，et al.IAP-targeted therapies for cancer.Oncogene，2008，27（48）:6252-6275.

15.Lavrik I，Golks A，Krammer PH.Death receptor signaling.J Cell Sci，2005，118（Pt 2）: 265-267.

16.Li X，Fan R，Zou X，et al.Inhibitory effect of recombinant adenovirus carrying immunocaspase-3on hepatocellular carcinoma.Biochem Bioohys Res Commun，2007，358（2）:489-494.

17.Lopes RB，Gangeswaran R，McNeish IA，et al.Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer，2007，120（11）:2344-2352.

18.Miquel C，Borrini F，Grandjouan S，et al.Role of bax mutations in apoptosis in colorectal cancers with microsatellite instability.Am J Clin Pathol，2005，23（4）:562-570.

19.Ohnishi K，Scuric Z，Schiesti RH，et al.siRNA targeting NBS1or XIAP increases radiation sensitivity of human cancer cells independent of TP53status.Radiat Res 2006，166: 454-62.

20.Oren M，Rotter V.Introduction:p53--the first twenty years.Cell Mol Life Sci，1999，55 （1）:9-11.

21.Philchenkov A，Zavelevich M，Kroczak TJ，et al.Caspases and cancer:mechanisms of inactivation and new treatment modalities.Exp Oncol，2004，26（2）:82-97.

22.Shen XG，Wang C，Li Y，et al.Downregulation of caspase-9is a frequent event in patients with stageⅡcolorectal cancer and correlates with poor clinical outcome.Colorectal Dis， 2010，12（12）:1213-1218.

23.Small S，Keerthivasan G，Huang Z，et al.Overexpression of survivin initiates haematologic malignancies in vivo.Leukaemia，2010，24（11）:1920-1926.

24.Slatter TL，Hung N，Campbell H，et al.Hyperproliferation，cancer，and inflammation in mice expressing aΔ133p53-like isoform.Blood，2011，117（19）:5166-5177.

25.Vikhanskaya F，Lee MK，Mazzoletti M，et al.Cancer-derived p53mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53.Nucleic Acids Res，2007，35（6）:2093-2104.

26.Vucic D，Fairbrother WJ.The inhibitor of apoptosis proteins as therapeutic targets in cancer.Clin Cancer Res，2007，13（20）:5995-6000.

27.Vucic D，Stennicke HR，Pisabarro MT，et al.ML-IAP，a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.Curr Biol，2000，10（21）:1359-1366.

28.Wei Y，Fan T，Yu M.Inhibitor of apoptosis proteins and apoptosis.Acta Biochim Biophys Sin（Shanghai），2008，40（4）:278-288.

29.Yamabe K，Shimizu S，Ito T，et al.Cancer gene therapy using apro-apoptotic gene，caspase-3.Gene Ther，1999，6（12）:1952-1959.